Brookline Capital Downgrades Forte Biosciences to Hold

Brookline Capital analyst Kumaraguru Raja downgrades Forte Biosciences (NASDAQ:FBRX) from Buy to Hold.

Brookline Capital analyst Kumaraguru Raja downgrades Forte Biosciences (NASDAQ:FBRX) from Buy to Hold.

Total
0
Shares
Related Posts